The anti-VLA-4 antibody natalizumab induces erythroblastaemia in the majority of the treated patients with multiple sclerosis
Robier, C., Amouzadeh-Ghadikolai, O., Bregant, C., Diez, J., Melinz, K., Neubauer, M., Quasthoff, S.Volume:
20
Language:
english
Journal:
Multiple Sclerosis Journal
DOI:
10.1177/1352458514521307
Date:
August, 2014
File:
PDF, 305 KB
english, 2014